Yoshitaka Morita
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 15, 2025
Comment on: NK cell cytotoxicity is markedly reduced in younger patients with rheumatoid arthritis treated with JAK inhibitors: Reply.Takahiko Akagi, Yoshitaka Morita, Kazuhisa Nakano
|Jun 05, 2025
NK cell cytotoxicity is markedly reduced in younger patients with RA treated with JAK inhibitors.Takahiko Akagi, Yasumitsu Nishimura, Shunichi Fujita
|Jun 02, 2025
Switching to IL-6 inhibitors or abatacept in elderly patients with rheumatoid arthritis achieving low disease activity with JAK inhibitors: a pilot study.Shunichi Fujita, Yoshitaka Morita, Kazuhisa Nakano
|Jun 14, 2020
Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis.Takahiko Akagi, Tomoyuki Mukai, Takafumi Mito
|Mar 10, 2020
In vivo analysis of thrombus formation in arthritic mice.Shoko Tsuji, Tomoyuki Mukai, Hiroyasu Hirano
|Aug 21, 2019
Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.S Tsuji, H Matsuzaki, M Iseki
Pageof 1
